ipl-logo

Prescription Drug Cost Essay

570 Words3 Pages

The American healthcare system is a most expensive in the world. According to Kennedy and Wood (2016), many people are nonadherence to medications due to the cost, making it harder to afford the medicines, which in return “linked to the exacerbation of chronic conditions, increases health care use, and greater health system costs” (p. 1804). The EpiPen has been in the news due to the cost increase of 550% in the last eight years (Meyer, 2016, para. 5). As mentioned by Meyer (2016), “A Kaiser Family Foundation survey last month found 77% of Americans say prescription drug costs are unreasonable, with 82% backing giving Medicare the power to negotiate drug prices” (para. 7). The drug industry lobbied Congress and was successful to bar Medicare from negotiating drug prices in the Part D program in 2003 (Meyer, 2016, para. 13). The brand-name drugs are more expensive than generics; and the doctors who receive payments from the pharmaceutical industry prescribe more brand-name drugs to their patients (“The Cost of,” 2016). …show more content…

The generic name drugs cost 80-85% less than the brand-name version, making it affordable as well as increasing the patient compliance (“The Cost of,” 2016). According to the article “The cost of generic and name-brand drugs” (2016), 80% of the prescriptions are filled with generic medicines in the USA. The state governments, nonprofit groups, and some pharmaceutical companies offer assistance programs for the patients who cannot afford medications; however, the patients have to apply for eligibility to receive medication assistance (WebMD, 2015, p. 1). The state government programs coordinate with Medicare to provide assistance to the elderly, disabled, and low-income population as well as patients with chronic conditions such as HIV or end-stage kidney disease (WebMD, 2015, p.

Show More
Related
431 Words | 2 Pages

The central issue of the article is the distinct nature of the charge by Minnesota’s Prescription Drug Affordability Board that distinguishes it from the same initiatives in other states. Being an innovative drug pricing regulatory body,

Read More
342 Words | 2 Pages

Right now in the United States of America, there is a monopoly that exists that involves epinephrine auto-injectors. EpiPen is the United States only supplier of these auto-injectors because other brands have suffered setbacks and failures, patent protection laws, and because there are currently no generic versions of EpiPen in the United States (Johnson). This monopoly was not a problem until Mylan bought Meda AB in 2007 (Paton). “Since Mylan bought the rights to EpiPen in 2007, it has raised the price on 15 separate occasions, bringing the current list price to $608 for a two-pack up from about $50 a pen in 2007” (Mole). This has been a price increase of more than 500%, and this shows that Mylan has been using the monopoly to its advantage.

Read More
785 Words | 4 Pages

In 2007 Mylan bought the rights to the EpiPen from a German company called Merck KGaA. Sense then they have increased the price of the epipen by over 550 percent in the last eight years. During these same eight years the CEO can also be seen to have a dramatic salary increase from 2.5 to 19 million - a total of 16.5 million dollars pay increase (Gerson, Madeleine). The price for a EpiPen now is around 600 dollars opposed to what it was in 2007, a measly 94 dollars. Madeleine Gerson states that, “Because of Mylan 's control of the drug market for epinephrine injections, patients have few options other than to purchase an EpiPen.” There is no generic version of the epipen, forcing people to either pay these outrageous prices or take the risk of going without one.

Read More
1860 Words | 8 Pages

In the U.S. there currently is no government regulation when it comes to prescription drug prices, granting pharmaceutical companies complete control over their prices. Unfortunately, many companies take advantage of this freedom and there is a lot of corporate greed that occurs when setting the prices of these life-saving medications. While research, development, and trial for these new drugs are extremely expensive and are taken into account when pharmaceutical companies set their prices, it is not justifiable when these prices are exceeding inflation rates. Moreover, “Drug expenditures nearly doubled between 1980 and 1991 (from $15.8 billion to $29.2 billion), even after adjusting for inflation. Much of this increase was driven by increases in prescription drug prices, which rose by more than twice the rate of inflation between 1980 and 1991” (Gross).

Read More
278 Words | 2 Pages

Lori Chordas claims in her viewpoint that the production of generic versions of prescription drugs cuts the price of medication notably. Brand names can cost from thirty to eighty percent more than generic versions of the same medication. More Americans are recognizing the savings associated with buying generic brands instead of brand name. Generic drugs made up sixty five percent of prescription drugs distributed in 200 according to IMS Health.

Read More
895 Words | 4 Pages

Over the decades, the pharmaceutical industry has experienced a slow and steady growth driven by large pharmaceutical companies that capture a large market share. These industries are however facing many challenges like lack of innovation, patent expiration, generics and its competitions and poor product pipelines and difficulties in bringing new drugs to the market quickly and effectively. The so called block-buster drugs bring in most of revenues for the big pharma companies. A drug is called a block-buster if it generates $ 1 Billion in annual revenue for the company that generates it. The emergence of patent cliff incurred heavy losses to the company due to patent expirations and the generic companies within no time make a newer version

Read More
522 Words | 3 Pages

In America many patients and public are suffering due to the high prices on medical drugs. This has resulted in ‘more than three in four Americans’ want the government to cap what drugs companies

Read More
1173 Words | 5 Pages

Much of this debate about how we control the price of prescription drugs was spurred by the cost of the Epi-Pens. Because of all of this controversy, a major question has been raised; have the price changes been justified through increases in quality or other benefits the company has begun offering? I believe

Read More
445 Words | 2 Pages

Based on a chart developed by the Obama administration the amount paid by the individual for brand name drugs distributed to the general public from 47.5% to 25% from 2015 through 2020. At the same time, the percentage paid on generic drugs during this coverage gap decreases existentially from 2020 to 2015 bringing the percentage from a mountainous 79% to a measly 25% in just that 5 year period. “This legislation includes physician payment reforms that encourage physicians, hospitals, and other providers to join together to form accountable care organizations to gain efficiencies and improve quality of care.” (Obamacare: Pros and Cons, page 3) According to Forbes, “The Affordable Care Act, Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between $10 billion and $35 billion in additional profits over the next decade.”

Read More
419 Words | 2 Pages

With prescription drugs, sellers sell for as much as they can sell and buyers buy for as cheap as they can they can (Barrueta, 112). Through this, ideally, buyers and sellers find a common ground where the result is hopefully beneficial for both sides; buyer and seller. Sellers have price elasticity, and price often depends on optionality vs indispensability. Optionality is the value the seller takes in having additional investments aka is it worth it for the seller to be making a certain investment or not and indispensability is the absolute necessity of the seller to make the investments aka can they afford neglecting certain investments (Barrueta, 113). Moreover, this is protected by law through patents and other market exclusivity so that one side can

Read More
95 Words | 1 Pages

About 1 and every 5 Americans today, are unable to afford the medicine that need to get better. ( ) Many of the major pharmaceutical companies are making billions in profit by having the control of selling and distributing prescribed medication. This leads the United States in a situation that the American people are paying some of the highest prices in the world for prescription drugs. These drugs companies making heaps of profit by controlling the market which leads to millions of Americans not being able to afford the prescription medicine that they desperately

Read More
2470 Words | 10 Pages

A man’s wife is dying of cancer and there is one medicine that can save her. This drug is rare as it is only made by one chemist, and as a result, the price is exorbitant, ten times the actual cost of production. The man cannot afford to pay it and must either forgo the chance to save his wife’s life, or undertake desperate measures. Now, this scenario could be viewed as the Heinz Dilemma, a story often told in order to gauge the levels of moral reasoning, but unfortunately, it could also serve as an example of what the United States’ healthcare system has become. Prescription drug prices have been rapidly rising, so much so that they may not reasonably be attainable for the typical citizen.

Read More
809 Words | 4 Pages

The National Health Service (NHS) of England set the costs of expensive drugs, like the medicines for the treatment of AIDS patients, for a fraction of the retail price – Why can’t the USA – the most richest and industrialized country in the world- follow suit and make most essential generic medicines affordable to each and every citizen? This is the main intent of the

Read More
778 Words | 4 Pages

Prescription Drugs have become a part of popular culture due to the influence of healthcare professionals. Physicians who get rewarded from drug makers, generally prescribe more brand-name drugs. “As payments increased, brand-name prescribing rates tended to as well.” Because there is an incentive involved for doctors, they promote prescription drugs as the popular choice.

Read More
1476 Words | 6 Pages

In the United States at present, it is evident that the cost of health care is on the rise which can be partly due to new/improved medical technologies, advancements in medicine, the increase in consumers’ demands and consumers’ utilization, increased labor costs, the aging of the population, lack of information technology, unhealthy lifestyles, etc. These improvements/advancements in health care technologies and medicine have improved and prolonged the lives of many U.S. citizens, but not without a high cost rate. The cost of health care has risen faster than any other consumer costs over the last ten years. It is projected that by the year 2016, which is near, the total amount spent on health care will increase to $4.2 trillion,

Read More

More about Prescription Drug Cost Essay

Related Topics

Open Document